CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
23 hedge funds and large institutions have $631K invested in COSCIENS Biopharma Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
65% less call options, than puts
Call options by funds: $110K | Put options by funds: $315K
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
23
Holding in Top 10
–
Calls
$110K
Puts
$315K
Top Buyers
| 1 | +$25.6K | |
| 2 | +$12.3K | |
| 3 | +$10.9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2K |
| 5 |
VF
Virtu Financial
New York
|
+$1.94K |
Top Sellers
| 1 | -$68K | |
| 2 | -$61.6K | |
| 3 | -$53K | |
| 4 |
Millennium Management
New York
|
-$20K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$15.1K |